CliffBio
small molecule

APRESAZIDE

HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE

Loss of exclusivity—loss of exclusivity
CompanyNovartis →See this company's full patent-cliff portfolio

Drug detail

Brand nameAPRESAZIDE
Active ingredientHYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
Strength25MG;25MG
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
Marketing statusDISCN

More from Novartis

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.